Detection of Rare Clinically Actionable Mutations in NSCLC Metastatic to the Brain by Targeted Next Generation Sequencing

被引：0
|
作者：
Tafe, Laura J. [1 ]
Maung, Ko K. [2 ]
Weinstein, Shelsey J. [2 ]
Tsongalis, Gregory J. [1 ]
Dragnev, Konstantin H. [2 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA
[2] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
brain metastases; NSCLC; Molecular genotyping;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI13.11
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [1] The efficacy of targeted next-generation sequencing for detection of clinically actionable mutations in cancer
    Wen, Yu-Ye
    Fang, Erica
    Li, Yanchun
    Carmack, Condie Edwin
    Li, Marilyn M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma
    Jeck, William R.
    Parker, Joel
    Carson, Craig C.
    Shields, Janiel M.
    Sambade, Maria J.
    Peters, Eldon C.
    Burd, Christin E.
    Thomas, Nancy E.
    Chiang, Derek Y.
    Liu, Wenjin
    Eberhard, David A.
    Ollila, David
    Grilley-Olson, Juneko
    Moschos, Stergios
    Hayes, D. Neil
    Sharpless, Norman E.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (04) : 653 - 663
  • [3] Next generation cancer gene sequencing for clinically actionable mutations
    Wen, Yu-Ye
    Douglas, Ganka
    Hu, Xiafeng
    Millham, Michele
    Cifuentes, Francisco
    Peters, Garrick
    Carmack, Condie Edwin
    Li, Marilyn
    [J]. CANCER RESEARCH, 2012, 72
  • [4] Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
    Lu, Hongyang
    Yang, Shifeng
    Zhu, Huineng
    Tong, Xiaoling
    Xie, Fajun
    Qin, Jing
    Han, Na
    Wu, Xue
    Fan, Yun
    Shao, Yang W.
    Mao, Weimin
    [J]. BMC CANCER, 2018, 18
  • [5] Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
    Hongyang Lu
    Shifeng Yang
    Huineng Zhu
    Xiaoling Tong
    Fajun Xie
    Jing Qin
    Na Han
    Xue Wu
    Yun Fan
    Yang W. Shao
    Weimin Mao
    [J]. BMC Cancer, 18
  • [6] Is Targeted next Generation Sequencing Superior to Older Methods at Identifying Actionable Mutations in Selected NSCLC Patients?
    Cooper, Wendy
    Kraitsek, Spiridoula
    Selinger, Christina
    Tran, Thang
    Kohonen-Corish, Maija
    Kao, Steven
    O'Toole, Sandra
    Yu, Bing
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S708 - S708
  • [7] Detecting Clinically Actionable Mutations in Leukemia Using a Novel Targeted Next-Generation Sequencing Panel
    Chang, F.
    Liu, L.
    Fang, E.
    Zhang, G.
    Li, Y.
    Li, M. M.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 869 - 869
  • [8] Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing
    Krissie Lenting
    Corina N. A. M. van den Heuvel
    Anne van Ewijk
    Duaa ElMelik
    Remco de Boer
    Elizabeth Tindall
    Ge Wei
    Benno Kusters
    Maarten te Dorsthorst
    Mark ter Laan
    Martijn A. Huynen
    William P. Leenders
    [J]. Acta Neuropathologica Communications, 7
  • [9] Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing
    Lenting, Krissie
    van den Heuvel, Corina N. A. M.
    van Ewijk, Anne
    ElMelik, Duaa
    de Boer, Remco
    Tindall, Elizabeth
    Wei, Ge
    Kusters, Benno
    te Dorsthorst, Maarten
    ter Laan, Mark
    Huynen, Martijn A.
    Leenders, William P.
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01) : 185
  • [10] TARGETED NEXT GENERATION SEQUENCING IN MALIGNANT SUPRATENTORIAL PEDIATRIC BRAIN TUMORS REVEALS ACTIONABLE MUTATIONS
    Cole, Bonnie
    Pritchard, Colin
    Anderson, Maia
    Leary, Sarah
    [J]. NEURO-ONCOLOGY, 2015, 17 : 14 - 14
12345